Advertisement
The U.S. government will pay Johnson & Johnson $1 billion for 100 million doses of its vaccine if it is approved by the U.S. Food and Drug Administration

Johnson & Johnson Makes $1 Billion Vaccine Deal

0
Company has said it will offer doses at a not-for-profit cost to provide global access to the vaccine
As COVID-19 cases continue to surge across America

Scientists Call for Broader Use of Faster COVID-19 Tests

0
Currently, most tests rely on complex laboratory procedures, such as polymerase chain reaction
Physicians say prior authorization continues to interfere with patient care and can lead to adverse clinical consequences

Health Plans Not Implementing Prior Authorization Reforms

0
Findings based on American Medical Association survey of practicing physicians' experiences
Higher levels of bisphenol A

Bisphenol A Linked to More Asthma Symptoms in Young Boys

0
Study shows exposure to bisphenol A is associated with more asthma symptoms in low-income boys
Population-wide testing and effective contact tracing are necessary to prevent an epidemic rebound following school reopening in the United Kingdom; and severe acute respiratory syndrome coronavirus 2 transmission rates were low in an educational setting in Australia

Study Looks at Optimal Strategy for Reopening Schools in U.K.

0
Second study from Australia shows low SARS-CoV-2 transmission rates in educational setting
Maryland-based Novavax said Tuesday that preliminary trials of an experimental COVID-19 vaccine were promising.

Experimental COVID-19 Vaccine Shows Encouraging Results

0
One study revealed that 56 people made high levels of antibodies with no adverse side effects
As the daily U.S. COVID-19 death toll averaged more than 1

Seven States Join Pact to Speed COVID-19 Testing

0
Bipartisan plan illustrates just how bad testing delays are across the country
Acute flaccid myelitis mainly occurs during August to November

CDC Describes 238 Confirmed Cases of Acute Flaccid Myelitis

0
Median patient age was 5.3 years; 86 percent of patients had onset during August to November
Probiotics are not recommended for most digestive conditions

Probiotics Not Recommended for Most Digestive Conditions

0
Probiotics for Crohn disease, ulcerative colitis, IBS, C. difficile should be used only in context of clinical trial
A distance learning program is effective for reducing outpatient prescribing for pediatric acute respiratory tract infection visits

Program Cuts Outpatient Antibiotic Rx for Peds Respiratory Infections

0
Distance learning program includes online tutorials, webinars; video vignettes; individualized feedback